Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Essure® hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy.

Mijatovic V, Dreyer K, Emanuel MH, Schats R, Hompes PG.

Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):42-5. doi: 10.1016/j.ejogrb.2011.12.001.

PMID:
22200254
2.

Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy.

Mijatovic V, Veersema S, Emanuel MH, Schats R, Hompes PG.

Fertil Steril. 2010 Mar 1;93(4):1338-42. doi: 10.1016/j.fertnstert.2008.11.022.

PMID:
19147140
3.

Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization.

Galen DI, Khan N, Richter KS.

J Minim Invasive Gynecol. 2011 May-Jun;18(3):338-42. doi: 10.1016/j.jmig.2011.01.016.

PMID:
21420911
4.

Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated.

Matorras R, Rabanal A, Prieto B, Diez S, Brouard I, Mendoza R, Exposito A.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(1):54-9. doi: 10.1016/j.ejogrb.2013.02.008.

PMID:
23561020
5.

ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients.

Ozgur K, Bulut H, Berkkanoglu M, Coetzee K, Kaya G.

Reprod Biomed Online. 2014 Jul;29(1):113-8. doi: 10.1016/j.rbmo.2014.03.005.

PMID:
24813749
6.

Essure(®) for management of hydrosalpinx prior to in vitro fertilisation-a systematic review and pooled analysis.

Arora P, Arora RS, Cahill D.

BJOG. 2014 Apr;121(5):527-36. doi: 10.1111/1471-0528.12533. Review.

8.

Essure treatment of hydrosalpinges.

Hitkari JA, Singh SS, Shapiro HM, Leyland N.

Fertil Steril. 2007 Dec;88(6):1663-6.

PMID:
17490660
9.

Proximal occlusion of hydrosalpinges by Essure(®) before assisted reproduction techniques: a French survey.

Legendre G, Moulin J, Vialard J, Ziegler DD, Fanchin R, Pouly JL, Watrelot A, Belaisch Allart J, Massin N, Fernandez H.

Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:300-4. doi: 10.1016/j.ejogrb.2014.07.020.

PMID:
25201610
10.

Can laparoscopic removal of Essure device before embryo transfer correct poor reproductive outcome pattern in IVF? A case report.

Salem SA, Peck AC, Salem RD, Sills ES.

Clin Exp Obstet Gynecol. 2014;41(2):219-22.

PMID:
24779258
11.

Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx.

Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglou E, Creatsas G.

Fertil Steril. 2006 Dec;86(6):1642-9.

PMID:
17069813
12.

Diagnostic accuracy of hysterosalpingo-foam-sonography to confirm tubal occlusion after Essure® placement as treatment for hydrosalpinges.

Dreyer K, Hompes PG, Mijatovic V.

Reprod Biomed Online. 2015 Apr;30(4):421-5. doi: 10.1016/j.rbmo.2014.12.009.

PMID:
25682307
13.

Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: an RCT.

Dreyer K, Lier MC, Emanuel MH, Twisk JW, Mol BW, Schats R, Hompes PG, Mijatovic V.

Hum Reprod. 2016 Sep;31(9):2005-16. doi: 10.1093/humrep/dew050.

PMID:
27209341
14.

Essure a novel option for the treatment of hydrosalpinx: a case series and literature review.

Lorente González J, Ríos Castillo JE, Pomares Toro E, Romero Nieto MI, Castelo-Branco C, Arjona Berral JE.

Gynecol Endocrinol. 2016;32(2):166-70. doi: 10.3109/09513590.2015.1103221. Review.

PMID:
26513546
15.

[Adiana(®) hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization: a case report].

Legendre G, Gallot V, Levaillant JM, Capmas P, Fernandez H.

J Gynecol Obstet Biol Reprod (Paris). 2013 Jun;42(4):401-4. doi: 10.1016/j.jgyn.2013.03.008. French.

16.

Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Johnson NP, Mak W, Sowter MC.

Cochrane Database Syst Rev. 2001;(3):CD002125. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD002125.

PMID:
11687014
17.
18.

[Current position of Essure(®) micro-insert in the management of hydrolsalpinges before in vitro fertilization].

Sonigo C, Collinet P, Rubod C, Catteau-Jonard S.

Gynecol Obstet Fertil. 2013 Feb;41(2):133-8. doi: 10.1016/j.gyobfe.2012.12.010. French.

PMID:
23375476
19.

Salpingectomy or proximal tubal occlusion of unilateral hydrosalpinx increases the potential for spontaneous pregnancy.

Sagoskin AW, Lessey BA, Mottla GL, Richter KS, Chetkowski RJ, Chang AS, Levy MJ, Stillman RJ.

Hum Reprod. 2003 Dec;18(12):2634-7.

PMID:
14645184
20.

[Utilization of Essure® micro-insert for hydrosalpynx occlusion in infertile women].

Thébault N, Broux PL, Moy L, Vialard J.

J Gynecol Obstet Biol Reprod (Paris). 2012 Apr;41(2):145-50. doi: 10.1016/j.jgyn.2011.12.003. French.

Supplemental Content

Support Center